CNSX:TRULPharmaceuticals
Trulieve Cannabis (CNSX:TRUL) Quarterly Loss Of US$44.3m Tests Bullish Profitability Narratives
Trulieve Cannabis (CNSX:TRUL) has wrapped up FY 2025 with fourth quarter revenue of US$293.1 million and a basic EPS loss of US$0.23, keeping the spotlight firmly on how quickly the core business can move closer to breakeven. Over the past six quarters, revenue has moved within a relatively tight band from US$284.3 million in Q3 2024 to US$302.1 million in Q2 2025. Quarterly basic EPS losses have ranged from US$0.07 to US$0.32, signaling that margin pressure remains a central theme for...